Wall Street is positive on IO Biotech Inc (IOBT). On average, analysts give IOBT a Strong Buy rating. The average price target is $20.5, which means analysts expect the stock to climb by 95.05% over the next twelve months. That average ranking earns IOBT an Analyst Rating of 70, which is better than 70% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating IOBT a Strong Buy today. Find out what this means to you and get the rest of the rankings on IOBT!